4//SEC Filing
McGrath Yvonne 4
Accession 0000899243-21-023000
CIK 0001808865other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:35 PM ET
Size
9.0 KB
Accession
0000899243-21-023000
Insider Transaction Report
Form 4
McGrath Yvonne
Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-06-08$20.00/sh−7,927$158,540→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-08−7,927→ 95,123 totalExercise: $4.23Exp: 2030-05-01→ Common Stock (1,402 underlying) - Exercise/Conversion
Common Stock
2021-06-08$4.23/sh+7,927$33,531→ 7,927 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2021.
- [F2]One-fourth of the shares subject to the stock option vest on the one-year anniversary of the vesting commencement date, subject to the reporting persons continuous service relationship with the Issuer through such date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting persons continuous service relationship with the Issuer through each applicable vesting date.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816213
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 5:35 PM ET
- Size
- 9.0 KB